Cargando…

Triple-Negative Breast Cancer: Current Understanding and Future Therapeutic Breakthrough Targeting Cancer Stemness

Triple-negative breast cancer (TNBC) is cancer that tested as negative for estrogen receptors (ER), progesterone receptors (PR), and excess human epidermal growth factor receptor 2 (HER2) protein which accounts for 15%–20% of all breast cancer cases. TNBC is considered to be a poorer prognosis than...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Kha-Liang, Kuo, Yung-Che, Ho, Yuan-Soon, Huang, Yen-Hua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6769912/ https://www.ncbi.nlm.nih.gov/pubmed/31505803 http://dx.doi.org/10.3390/cancers11091334

Ejemplares similares

Effects of Cancer Stem Cells in Triple-Negative Breast Cancer and Brain Metastasis: Challenges and Solutions
por: Lee, Kha-Liang, et al.
Publicado: (2020)

Rare subtypes of triple negative breast cancer: Current understanding and future directions
por: Thomas, Alexandra, et al.
Publicado: (2023)

Triple-negative breast cancer therapy: Current and future perspectives (Review)
por: Won, Kwang-Ai, et al.
Publicado: (2020)

Triple-negative breast cancer: current perspective on the evolving therapeutic landscape
por: Mehanna, Joe, et al.
Publicado: (2019)

Precision Medicine and Triple-Negative Breast Cancer: Current Landscape and Future Directions
por: Hossain, Fokhrul, et al.
Publicado: (2021)

Immunotherapy for Metastatic Triple Negative Breast Cancer: Current Paradigm and Future Approaches
por: Geurts, Veerle, et al.
Publicado: (2023)

Immune Checkpoint Inhibition for Triple-Negative Breast Cancer: Current Landscape and Future Perspectives
por: Yi, Huimei, et al.
Publicado: (2021)

Systemic Therapy for Metastatic Triple Negative Breast Cancer: Current Treatments and Future Directions
por: Morrison, Laura, et al.
Publicado: (2023)

Niche Modulation of IGF-1R Signaling: Its Role in Stem Cell Pluripotency, Cancer Reprogramming, and Therapeutic Applications
por: Chen, Pei-Chin, et al.
Publicado: (2021)

Pathogenesis and Potential Therapeutic Targets for Triple-Negative Breast Cancer
por: Li, Chia-Jung, et al.
Publicado: (2021)

Stemness signature and targeted therapeutic drugs identification for Triple Negative Breast Cancer
por: Gul, Samina, et al.
Publicado: (2023)

Back to the Future, Current Trends in Breakthrough Pain Treatments
por: Watson, Max
Publicado: (2011)

Understanding Patterns of Brain Metastasis in Triple-Negative Breast Cancer and Exploring Potential Therapeutic Targets
por: Lv, Yan, et al.
Publicado: (2021)

Current Therapeutic Strategies for Metastatic Triple-Negative Breast Cancer: From Pharmacists’ Perspective
por: Li, Shuanghe, et al.
Publicado: (2022)

Current approaches in treatment of triple-negative breast cancer
por: Wahba, Hanan Ahmed, et al.
Publicado: (2015)

RNA-Based Therapeutics: Current Developments in Targeted Molecular Therapy of Triple-Negative Breast Cancer
por: Haque, Sakib, et al.
Publicado: (2021)

CDK4 regulates cancer stemness and is a novel therapeutic target for triple-negative breast cancer
por: Dai, Meiou, et al.
Publicado: (2016)

Potential of Cellular Therapy for ALS: Current Strategies and Future Prospects
por: Lin, Ting-Jung, et al.
Publicado: (2022)

Eribulin in Triple Negative Metastatic Breast Cancer: Critic Interpretation of Current Evidence and Projection for Future Scenarios
por: Pizzuti, Laura, et al.
Publicado: (2019)

Central Nervous System Metastases from Triple-Negative Breast Cancer: Current Treatments and Future Prospective
por: Kadamkulam Syriac, Arun, et al.
Publicado: (2022)

Emerging Role of PARP Inhibitors in Metastatic Triple Negative Breast Cancer. Current Scenario and Future Perspectives
por: Barchiesi, Giacomo, et al.
Publicado: (2021)

Chronic Niche Inflammation in Endometriosis-Associated Infertility: Current Understanding and Future Therapeutic Strategies
por: Lin, Yi-Heng, et al.
Publicado: (2018)

Downregulation of TAB182 promotes cancer stem-like cell properties and therapeutic resistance in triple-negative breast cancer cells
por: He, Huan, et al.
Publicado: (2023)

Triple-Negative Breast Cancer: Adjuvant Therapeutic Options
por: Gucalp, Ayca, et al.
Publicado: (2011)

Therapeutic landscape in mutational triple negative breast cancer
por: Shi, Yaqin, et al.
Publicado: (2018)

Targeted Therapeutic Strategies for Triple-Negative Breast Cancer
por: Li, Ying, et al.
Publicado: (2021)

Targeting Cancer Stem Cells in Triple-Negative Breast Cancer
por: Park, So-Yeon, et al.
Publicado: (2019)

Regulation of cancer stem cells in triple negative breast cancer
por: Fultang, Norman, et al.
Publicado: (2021)

Evaluating the therapeutic potential of ADAR1 inhibition for triple-negative breast cancer
por: Kung, Che-Pei, et al.
Publicado: (2020)

Corrigendum: Potential of cellular therapy for ALS: current strategies and future prospects
por: Lin, Ting-Jung, et al.
Publicado: (2023)

Celastrol and Triptolide Suppress Stemness in Triple Negative Breast Cancer: Notch as a Therapeutic Target for Stem Cells
por: Ramamoorthy, Prabhu, et al.
Publicado: (2021)

On the understanding and feasibility of “Breakthrough” Osmosis
por: Wu, Jun Jie, et al.
Publicado: (2019)

Triple-negative breast cancer: current treatment strategies and factors of negative prognosis
por: Baranova, Anna, et al.
Publicado: (2022)

Triple-negative breast cancer: understanding Wnt signaling in drug resistance
por: Merikhian, Parnaz, et al.
Publicado: (2021)

Understanding and harnessing triple-negative breast cancer-related microbiota in oncology
por: Devoy, Ciaran, et al.
Publicado: (2022)

Current Progresses and Challenges of Immunotherapy in Triple-Negative Breast Cancer
por: Mediratta, Karan, et al.
Publicado: (2020)

Perspectives on Triple-Negative Breast Cancer: Current Treatment Strategies, Unmet Needs, and Potential Targets for Future Therapies
por: Gupta, Gagan K., et al.
Publicado: (2020)

Current and Future Role of Neoadjuvant Chemoimmunotherapy for Early Triple-Negative Breast Cancer: Which Way to Go Forward
por: Rizzo, Alessandro, et al.
Publicado: (2022)

Therapeutic Strategies for Metastatic Triple-Negative Breast Cancers: From Negative to Positive
por: Nandini, Dey, et al.
Publicado: (2021)

Novel therapeutic strategies for patients with triple-negative breast cancer
por: Zhang, Jun-Fei, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_9tfm16ept3o6nkcee6q4bhi7op